Company Filing History:
Years Active: 2016-2020
Title: Chang Tao: Innovator in Diabetes Treatment
Introduction
Chang Tao is a prominent inventor based in Westmead, Australia. He has made significant contributions to the field of diabetes treatment through his innovative research and patented inventions. With a total of three patents to his name, Chang is dedicated to advancing medical science and improving the lives of those affected by diabetes.
Latest Patents
One of Chang Tao's latest patents involves cells genetically modified to comprise pancreatic islet glucokinase and their uses. This invention relates to a population of cells that are genetically modified to produce insulin in a glucose-responsive manner. More specifically, these cells are designed to respond to physiologically relevant levels of glucose, making them particularly useful in therapeutic and prophylactic regimes aimed at treating diabetes. The transplantation of these cells into mammals requiring treatment can help ameliorate symptoms associated with diabetes. Additionally, this invention facilitates the design of in vitro screening systems for testing the therapeutic effectiveness and toxicity of potential adjunctive treatment regimes.
Career Highlights
Chang Tao is affiliated with the University of Technology Sydney, where he conducts his research and development work. His innovative approach to diabetes treatment has garnered attention in the scientific community, and his patents reflect his commitment to finding effective solutions for managing this chronic condition.
Collaborations
Chang collaborates with Ann Margaret Simpson, a fellow researcher, to further enhance the impact of their work in the field of diabetes treatment. Their combined expertise contributes to the advancement of medical research and the development of new therapeutic strategies.
Conclusion
Chang Tao's work in genetically modified cells for diabetes treatment exemplifies the potential of innovation in addressing critical health challenges. His contributions are paving the way for new therapeutic options that can significantly improve the quality of life for individuals living with diabetes.